The Discounted Cash Flow (DCF) valuation of Accelerate Diagnostics Inc (AXDX) is (192.94) USD. With the latest stock price at 0.03 USD, the upside of Accelerate Diagnostics Inc based on DCF is -567571.7%.
Based on the latest price of 0.03 USD and our DCF valuation, Accelerate Diagnostics Inc (AXDX) is a sell. selling AXDX stocks now will result in a potential gain of 567571.7%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 4.3% - 7.9% | 6.1% |
| Long-term Growth Rate | 3.0% - 4.1% | 3.5% |
| Fair Price | (1,881.69) - (106.63) | (192.94) |
| Upside | -5534490.1% - -313719.5% | -567571.7% |